img

Global In Vivo Toxicology Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global In Vivo Toxicology Market Research Report 2024

In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.
According to MRAResearch’s new survey, global In Vivo Toxicology market is projected to reach US$ 6164 million in 2033, increasing from US$ 4194.4 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Vivo Toxicology market research.
Key companies engaged in the In Vivo Toxicology industry include Thermo Fisher Scientific, Danaher, Charles River Laboratories, Labcorp, The Jackson Laboratory, Data Sciences International, Envigo, Eurofins Scientific and Perkinelmer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of In Vivo Toxicology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole In Vivo Toxicology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In Vivo Toxicology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Thermo Fisher Scientific
Danaher
Charles River Laboratories
Labcorp
The Jackson Laboratory
Data Sciences International
Envigo
Eurofins Scientific
Perkinelmer
SRI International
Taconic Biosciences
Wuxi Apptec
Segment by Type
Chronic Toxicity Testing
Sub-Chronic Toxicity Testing
Sub-Acute Toxicity Testing
Acute Toxicity Testing

Segment by Application


Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity(DART)
Other Toxicity Endpoints
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The In Vivo Toxicology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo Toxicology Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Chronic Toxicity Testing
1.2.3 Sub-Chronic Toxicity Testing
1.2.4 Sub-Acute Toxicity Testing
1.2.5 Acute Toxicity Testing
1.3 Market by Application
1.3.1 Global In Vivo Toxicology Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Immunotoxicity
1.3.3 Systemic Toxicity
1.3.4 Carcinogenicity
1.3.5 Genotoxicity
1.3.6 Developmental and Reproductive Toxicity(DART)
1.3.7 Other Toxicity Endpoints
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Toxicology Market Perspective (2018-2033)
2.2 In Vivo Toxicology Growth Trends by Region
2.2.1 Global In Vivo Toxicology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 In Vivo Toxicology Historic Market Size by Region (2018-2023)
2.2.3 In Vivo Toxicology Forecasted Market Size by Region (2024-2033)
2.3 In Vivo Toxicology Market Dynamics
2.3.1 In Vivo Toxicology Industry Trends
2.3.2 In Vivo Toxicology Market Drivers
2.3.3 In Vivo Toxicology Market Challenges
2.3.4 In Vivo Toxicology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Toxicology Players by Revenue
3.1.1 Global Top In Vivo Toxicology Players by Revenue (2018-2023)
3.1.2 Global In Vivo Toxicology Revenue Market Share by Players (2018-2023)
3.2 Global In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vivo Toxicology Revenue
3.4 Global In Vivo Toxicology Market Concentration Ratio
3.4.1 Global In Vivo Toxicology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo Toxicology Revenue in 2022
3.5 In Vivo Toxicology Key Players Head office and Area Served
3.6 Key Players In Vivo Toxicology Product Solution and Service
3.7 Date of Enter into In Vivo Toxicology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo Toxicology Breakdown Data by Type
4.1 Global In Vivo Toxicology Historic Market Size by Type (2018-2023)
4.2 Global In Vivo Toxicology Forecasted Market Size by Type (2024-2033)
5 In Vivo Toxicology Breakdown Data by Application
5.1 Global In Vivo Toxicology Historic Market Size by Application (2018-2023)
5.2 Global In Vivo Toxicology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America In Vivo Toxicology Market Size (2018-2033)
6.2 North America In Vivo Toxicology Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America In Vivo Toxicology Market Size by Country (2018-2023)
6.4 North America In Vivo Toxicology Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo Toxicology Market Size (2018-2033)
7.2 Europe In Vivo Toxicology Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe In Vivo Toxicology Market Size by Country (2018-2023)
7.4 Europe In Vivo Toxicology Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Toxicology Market Size (2018-2033)
8.2 Asia-Pacific In Vivo Toxicology Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific In Vivo Toxicology Market Size by Region (2018-2023)
8.4 Asia-Pacific In Vivo Toxicology Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vivo Toxicology Market Size (2018-2033)
9.2 Latin America In Vivo Toxicology Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America In Vivo Toxicology Market Size by Country (2018-2023)
9.4 Latin America In Vivo Toxicology Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Toxicology Market Size (2018-2033)
10.2 Middle East & Africa In Vivo Toxicology Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa In Vivo Toxicology Market Size by Country (2018-2023)
10.4 Middle East & Africa In Vivo Toxicology Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In Vivo Toxicology Introduction
11.1.4 Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher In Vivo Toxicology Introduction
11.2.4 Danaher Revenue in In Vivo Toxicology Business (2018-2023)
11.2.5 Danaher Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories In Vivo Toxicology Introduction
11.3.4 Charles River Laboratories Revenue in In Vivo Toxicology Business (2018-2023)
11.3.5 Charles River Laboratories Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Detail
11.4.2 Labcorp Business Overview
11.4.3 Labcorp In Vivo Toxicology Introduction
11.4.4 Labcorp Revenue in In Vivo Toxicology Business (2018-2023)
11.4.5 Labcorp Recent Development
11.5 The Jackson Laboratory
11.5.1 The Jackson Laboratory Company Detail
11.5.2 The Jackson Laboratory Business Overview
11.5.3 The Jackson Laboratory In Vivo Toxicology Introduction
11.5.4 The Jackson Laboratory Revenue in In Vivo Toxicology Business (2018-2023)
11.5.5 The Jackson Laboratory Recent Development
11.6 Data Sciences International
11.6.1 Data Sciences International Company Detail
11.6.2 Data Sciences International Business Overview
11.6.3 Data Sciences International In Vivo Toxicology Introduction
11.6.4 Data Sciences International Revenue in In Vivo Toxicology Business (2018-2023)
11.6.5 Data Sciences International Recent Development
11.7 Envigo
11.7.1 Envigo Company Detail
11.7.2 Envigo Business Overview
11.7.3 Envigo In Vivo Toxicology Introduction
11.7.4 Envigo Revenue in In Vivo Toxicology Business (2018-2023)
11.7.5 Envigo Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific In Vivo Toxicology Introduction
11.8.4 Eurofins Scientific Revenue in In Vivo Toxicology Business (2018-2023)
11.8.5 Eurofins Scientific Recent Development
11.9 Perkinelmer
11.9.1 Perkinelmer Company Detail
11.9.2 Perkinelmer Business Overview
11.9.3 Perkinelmer In Vivo Toxicology Introduction
11.9.4 Perkinelmer Revenue in In Vivo Toxicology Business (2018-2023)
11.9.5 Perkinelmer Recent Development
11.10 SRI International
11.10.1 SRI International Company Detail
11.10.2 SRI International Business Overview
11.10.3 SRI International In Vivo Toxicology Introduction
11.10.4 SRI International Revenue in In Vivo Toxicology Business (2018-2023)
11.10.5 SRI International Recent Development
11.11 Taconic Biosciences
11.11.1 Taconic Biosciences Company Detail
11.11.2 Taconic Biosciences Business Overview
11.11.3 Taconic Biosciences In Vivo Toxicology Introduction
11.11.4 Taconic Biosciences Revenue in In Vivo Toxicology Business (2018-2023)
11.11.5 Taconic Biosciences Recent Development
11.12 Wuxi Apptec
11.12.1 Wuxi Apptec Company Detail
11.12.2 Wuxi Apptec Business Overview
11.12.3 Wuxi Apptec In Vivo Toxicology Introduction
11.12.4 Wuxi Apptec Revenue in In Vivo Toxicology Business (2018-2023)
11.12.5 Wuxi Apptec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In Vivo Toxicology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Chronic Toxicity Testing
Table 3. Key Players of Sub-Chronic Toxicity Testing
Table 4. Key Players of Sub-Acute Toxicity Testing
Table 5. Key Players of Acute Toxicity Testing
Table 6. Global In Vivo Toxicology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global In Vivo Toxicology Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global In Vivo Toxicology Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global In Vivo Toxicology Market Share by Region (2018-2023)
Table 10. Global In Vivo Toxicology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global In Vivo Toxicology Market Share by Region (2024-2033)
Table 12. In Vivo Toxicology Market Trends
Table 13. In Vivo Toxicology Market Drivers
Table 14. In Vivo Toxicology Market Challenges
Table 15. In Vivo Toxicology Market Restraints
Table 16. Global In Vivo Toxicology Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global In Vivo Toxicology Market Share by Players (2018-2023)
Table 18. Global Top In Vivo Toxicology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Toxicology as of 2022)
Table 19. Ranking of Global Top In Vivo Toxicology Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by In Vivo Toxicology Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In Vivo Toxicology Product Solution and Service
Table 23. Date of Enter into In Vivo Toxicology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In Vivo Toxicology Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global In Vivo Toxicology Revenue Market Share by Type (2018-2023)
Table 27. Global In Vivo Toxicology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global In Vivo Toxicology Revenue Market Share by Type (2024-2033)
Table 29. Global In Vivo Toxicology Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global In Vivo Toxicology Revenue Market Share by Application (2018-2023)
Table 31. Global In Vivo Toxicology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global In Vivo Toxicology Revenue Market Share by Application (2024-2033)
Table 33. North America In Vivo Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America In Vivo Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America In Vivo Toxicology Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe In Vivo Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe In Vivo Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe In Vivo Toxicology Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific In Vivo Toxicology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific In Vivo Toxicology Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific In Vivo Toxicology Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America In Vivo Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America In Vivo Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America In Vivo Toxicology Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa In Vivo Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa In Vivo Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa In Vivo Toxicology Market Size by Country (2024-2033) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Detail
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific In Vivo Toxicology Product
Table 51. Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Danaher Company Detail
Table 54. Danaher Business Overview
Table 55. Danaher In Vivo Toxicology Product
Table 56. Danaher Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 57. Danaher Recent Development
Table 58. Charles River Laboratories Company Detail
Table 59. Charles River Laboratories Business Overview
Table 60. Charles River Laboratories In Vivo Toxicology Product
Table 61. Charles River Laboratories Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 62. Charles River Laboratories Recent Development
Table 63. Labcorp Company Detail
Table 64. Labcorp Business Overview
Table 65. Labcorp In Vivo Toxicology Product
Table 66. Labcorp Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 67. Labcorp Recent Development
Table 68. The Jackson Laboratory Company Detail
Table 69. The Jackson Laboratory Business Overview
Table 70. The Jackson Laboratory In Vivo Toxicology Product
Table 71. The Jackson Laboratory Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 72. The Jackson Laboratory Recent Development
Table 73. Data Sciences International Company Detail
Table 74. Data Sciences International Business Overview
Table 75. Data Sciences International In Vivo Toxicology Product
Table 76. Data Sciences International Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 77. Data Sciences International Recent Development
Table 78. Envigo Company Detail
Table 79. Envigo Business Overview
Table 80. Envigo In Vivo Toxicology Product
Table 81. Envigo Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 82. Envigo Recent Development
Table 83. Eurofins Scientific Company Detail
Table 84. Eurofins Scientific Business Overview
Table 85. Eurofins Scientific In Vivo Toxicology Product
Table 86. Eurofins Scientific Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 87. Eurofins Scientific Recent Development
Table 88. Perkinelmer Company Detail
Table 89. Perkinelmer Business Overview
Table 90. Perkinelmer In Vivo Toxicology Product
Table 91. Perkinelmer Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 92. Perkinelmer Recent Development
Table 93. SRI International Company Detail
Table 94. SRI International Business Overview
Table 95. SRI International In Vivo Toxicology Product
Table 96. SRI International Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 97. SRI International Recent Development
Table 98. Taconic Biosciences Company Detail
Table 99. Taconic Biosciences Business Overview
Table 100. Taconic Biosciences In Vivo Toxicology Product
Table 101. Taconic Biosciences Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 102. Taconic Biosciences Recent Development
Table 103. Wuxi Apptec Company Detail
Table 104. Wuxi Apptec Business Overview
Table 105. Wuxi Apptec In Vivo Toxicology Product
Table 106. Wuxi Apptec Revenue in In Vivo Toxicology Business (2018-2023) & (US$ Million)
Table 107. Wuxi Apptec Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vivo Toxicology Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global In Vivo Toxicology Market Share by Type: 2022 VS 2033
Figure 3. Chronic Toxicity Testing Features
Figure 4. Sub-Chronic Toxicity Testing Features
Figure 5. Sub-Acute Toxicity Testing Features
Figure 6. Acute Toxicity Testing Features
Figure 7. Global In Vivo Toxicology Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global In Vivo Toxicology Market Share by Application: 2022 VS 2033
Figure 9. Immunotoxicity Case Studies
Figure 10. Systemic Toxicity Case Studies
Figure 11. Carcinogenicity Case Studies
Figure 12. Genotoxicity Case Studies
Figure 13. Developmental and Reproductive Toxicity(DART) Case Studies
Figure 14. Other Toxicity Endpoints Case Studies
Figure 15. In Vivo Toxicology Report Years Considered
Figure 16. Global In Vivo Toxicology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global In Vivo Toxicology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global In Vivo Toxicology Market Share by Region: 2022 VS 2033
Figure 19. Global In Vivo Toxicology Market Share by Players in 2022
Figure 20. Global Top In Vivo Toxicology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Toxicology as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by In Vivo Toxicology Revenue in 2022
Figure 22. North America In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America In Vivo Toxicology Market Share by Country (2018-2033)
Figure 24. United States In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe In Vivo Toxicology Market Share by Country (2018-2033)
Figure 28. Germany In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific In Vivo Toxicology Market Share by Region (2018-2033)
Figure 36. China In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America In Vivo Toxicology Market Share by Country (2018-2033)
Figure 44. Mexico In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa In Vivo Toxicology Market Share by Country (2018-2033)
Figure 48. Turkey In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia In Vivo Toxicology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 51. Danaher Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 52. Charles River Laboratories Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 53. Labcorp Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 54. The Jackson Laboratory Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 55. Data Sciences International Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 56. Envigo Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 57. Eurofins Scientific Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 58. Perkinelmer Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 59. SRI International Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 60. Taconic Biosciences Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 61. Wuxi Apptec Revenue Growth Rate in In Vivo Toxicology Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed